Elanco delivered third-quarter results that included organic revenue growth of 9%, along with gross margin expansion of 350 basis points year over year, supported by strength in the higher-margin pet division.
Secular growth of global pet ownership should provide a continuous tailwind to the demand for Elanco products.
Regulatory scrutiny on antibiotics used in meat production may limit the total market of Elanco’s feed additive products.
Metric | ELAN | ZTS | MRK |
|---|---|---|---|
Price/Earnings (Normalized) | 24.28 | 12.07 | 109.00 |
Price/Book Value | 1.94 | 9.80 | 8.06 |
Price/Sales | 2.50 | 3.53 | 5.39 |
Price/Cash Flow | 19.53 | 10.53 | 16.40 |
Metric | ELAN | ZTS | MRK |
|---|---|---|---|
Quick Ratio | 0.86 | 1.20 | 0.78 |
Current Ratio | 2.09 | 2.35 | 1.35 |
Interest Coverage | 0.64 | 13.52 | 3.33 |
Metric | ELAN | ZTS | MRK |
|---|---|---|---|
Return on Assets (Normalized) | 0.67% | 18.40% | 2.53% |
Return on Equity (Normalized) | 1.36% | 75.90% | 7.02% |
Return on Invested Capital (Normalized) | 2.65% | 23.13% | 4.79% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|xC$fJGlj | LOCK|M#fy | $73B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|P>>>lSh | LOCK|t^fZ | $48B | |||
| Haleon PLC ADR HLN | LOCK|#%wyxR | LOCK|>fw | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|pp@<^dq$ | LOCK|LB< | $32B | |||
| Viatris Inc VTRS | LOCK|Tn<w!T< | LOCK|fs | $23B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|r>nM!w | LOCK|#z | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|@$>s@!y | LOCK|n? | $6B | |||
| Perrigo Co PLC PRGO | LOCK|phCMR!g | LOCK|?!& | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|BL@vkF | LOCK|v#$<Q | $2B |
United States